Tasks for Artificial Intelligence in Prostate MRI

Overview

Journal Eur Radiol Exp

Date 2022 Jul 30

PMID 35908102

Authors

Mason J Belue

Baris Turkbey

Affiliations

Soon will be listed here.

Abstract

The advent of precision medicine, increasing clinical needs, and imaging availability among many other factors in the prostate cancer diagnostic pathway has engendered the utilization of artificial intelligence (AI). AI carries a vast number of potential applications in every step of the prostate cancer diagnostic pathway from classifying/improving prostate multiparametric magnetic resonance image quality, prostate segmentation, anatomically segmenting cancer suspicious foci, detecting and differentiating clinically insignificant cancers from clinically significant cancers on a voxel-level, and classifying entire lesions into Prostate Imaging Reporting and Data System categories/Gleason scores. Multiple studies in all these areas have shown many promising results approximating accuracies of radiologists. Despite this flourishing research, more prospective multicenter studies are needed to uncover the full impact and utility of AI on improving radiologist performance and clinical management of prostate cancer. In this narrative review, we aim to introduce emerging medical imaging AI paper quality metrics such as the Checklist for Artificial Intelligence in Medical Imaging (CLAIM) and Field-Weighted Citation Impact (FWCI), dive into some of the top AI models for segmentation, detection, and classification.

Citing Articles

Prediction of adverse pathology in prostate cancer using a multimodal deep learning approach based on [F]PSMA-1007 PET/CT and multiparametric MRI.

Lin H, Yao F, Yi X, Yuan Y, Xu J, Chen L Eur J Nucl Med Mol Imaging. 2025; .

PMID: 39969539 DOI: 10.1007/s00259-025-07134-0.

Systematic Review of AI-Assisted MRI in Prostate Cancer Diagnosis: Enhancing Accuracy Through Second Opinion Tools.

Alqahtani S Diagnostics (Basel). 2024; 14(22).

PMID: 39594242 PMC: 11592433. DOI: 10.3390/diagnostics14222576.

Interpreting Prostate Multiparametric MRI: Beyond Adenocarcinoma - Anatomical Variations, Mimickers, and Post-Intervention Changes.

Yilmaz E, Esengur O, Gelikman D, Turkbey B Semin Ultrasound CT MR. 2024; 46(1):2-30.

PMID: 39580037 PMC: 11741936. DOI: 10.1053/j.sult.2024.11.001.

Targeted Prostate Biopsy: How, When, and Why? A Systematic Review.

Rebez G, Barbiero M, Simonato F, Claps F, Siracusano S, Giaimo R Diagnostics (Basel). 2024; 14(17).

PMID: 39272649 PMC: 11394632. DOI: 10.3390/diagnostics14171864.

AI in prostate MRI: enhancing accuracy and reducing overdiagnosis.

Turkbey B Nat Rev Urol. 2024; .

PMID: 39261564 DOI: 10.1038/s41585-024-00940-5.

References

Harmon S, Tuncer S, Sanford T, Choyke P, Turkbey B . Artificial intelligence at the intersection of pathology and radiology in prostate cancer. Diagn Interv Radiol. 2019; 25(3):183-188. PMC: 6521904. DOI: 10.5152/dir.2019.19125. View

Van Booven D, Kuchakulla M, Pai R, Frech F, Ramasahayam R, Reddy P . A Systematic Review of Artificial Intelligence in Prostate Cancer. Res Rep Urol. 2021; 13:31-39. PMC: 7837533. DOI: 10.2147/RRU.S268596. View

Ahmed H, El-Shater Bosaily A, Brown L, Gabe R, Kaplan R, Parmar M . Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017; 389(10071):815-822. DOI: 10.1016/S0140-6736(16)32401-1. View

Giganti F, Lindner S, Piper J, Kasivisvanathan V, Emberton M, Moore C . Multiparametric prostate MRI quality assessment using a semi-automated PI-QUAL software program. Eur Radiol Exp. 2021; 5(1):48. PMC: 8568748. DOI: 10.1186/s41747-021-00245-x. View

van Leeuwen K, Schalekamp S, Rutten M, van Ginneken B, de Rooij M . Artificial intelligence in radiology: 100 commercially available products and their scientific evidence. Eur Radiol. 2021; 31(6):3797-3804. PMC: 8128724. DOI: 10.1007/s00330-021-07892-z. View

Twilt J, van Leeuwen K, Huisman H, Futterer J, de Rooij M . Artificial Intelligence Based Algorithms for Prostate Cancer Classification and Detection on Magnetic Resonance Imaging: A Narrative Review. Diagnostics (Basel). 2021; 11(6). PMC: 8229869. DOI: 10.3390/diagnostics11060959. View

Syer T, Mehta P, Antonelli M, Mallett S, Atkinson D, Ourselin S . Artificial Intelligence Compared to Radiologists for the Initial Diagnosis of Prostate Cancer on Magnetic Resonance Imaging: A Systematic Review and Recommendations for Future Studies. Cancers (Basel). 2021; 13(13). PMC: 8268820. DOI: 10.3390/cancers13133318. View

Mongan J, Moy L, Kahn Jr C . Checklist for Artificial Intelligence in Medical Imaging (CLAIM): A Guide for Authors and Reviewers. Radiol Artif Intell. 2021; 2(2):e200029. PMC: 8017414. DOI: 10.1148/ryai.2020200029. View

Wang B, Lei Y, Tian S, Wang T, Liu Y, Patel P . Deeply supervised 3D fully convolutional networks with group dilated convolution for automatic MRI prostate segmentation. Med Phys. 2019; 46(4):1707-1718. PMC: 6453726. DOI: 10.1002/mp.13416. View

10.

Ushinsky A, Bardis M, Glavis-Bloom J, Uchio E, Chantaduly C, Nguyentat M . A 3D-2D Hybrid U-Net Convolutional Neural Network Approach to Prostate Organ Segmentation of Multiparametric MRI. AJR Am J Roentgenol. 2020; 216(1):111-116. DOI: 10.2214/AJR.19.22168. View

11.

Sanford T, Zhang L, Harmon S, Sackett J, Yang D, Roth H . Data Augmentation and Transfer Learning to Improve Generalizability of an Automated Prostate Segmentation Model. AJR Am J Roentgenol. 2020; 215(6):1403-1410. PMC: 8974988. DOI: 10.2214/AJR.19.22347. View

12.

Cao R, Mohammadian Bajgiran A, Afshari Mirak S, Shakeri S, Zhong X, Enzmann D . Joint Prostate Cancer Detection and Gleason Score Prediction in mp-MRI via FocalNet. IEEE Trans Med Imaging. 2019; 38(11):2496-2506. DOI: 10.1109/TMI.2019.2901928. View

13.

Ishioka J, Matsuoka Y, Uehara S, Yasuda Y, Kijima T, Yoshida S . Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm. BJU Int. 2018; 122(3):411-417. DOI: 10.1111/bju.14397. View

14.

Le M, Chen J, Wang L, Wang Z, Liu W, Cheng K . Automated diagnosis of prostate cancer in multi-parametric MRI based on multimodal convolutional neural networks. Phys Med Biol. 2017; 62(16):6497-6514. DOI: 10.1088/1361-6560/aa7731. View

15.

Tataru O, Vartolomei M, Rassweiler J, Virgil O, Lucarelli G, Porpiglia F . Artificial Intelligence and Machine Learning in Prostate Cancer Patient Management-Current Trends and Future Perspectives. Diagnostics (Basel). 2021; 11(2). PMC: 7924061. DOI: 10.3390/diagnostics11020354. View

16.

Garvey B, Turkbey B, Truong H, Bernardo M, Periaswamy S, Choyke P . Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia. Diagn Interv Radiol. 2014; 20(3):229-33. PMC: 4463345. DOI: 10.5152/dir.2014.13322. View

17.

van Leenders G, van der Kwast T, Grignon D, Evans A, Kristiansen G, Kweldam C . The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma. Am J Surg Pathol. 2020; 44(8):e87-e99. PMC: 7382533. DOI: 10.1097/PAS.0000000000001497. View

18.

Gaur S, Lay N, Harmon S, Doddakashi S, Mehralivand S, Argun B . Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation. Oncotarget. 2018; 9(73):33804-33817. PMC: 6173466. DOI: 10.18632/oncotarget.26100. View

19.

Turkbey B, Rosenkrantz A, Haider M, Padhani A, Villeirs G, Macura K . Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019; 76(3):340-351. DOI: 10.1016/j.eururo.2019.02.033. View

20.

Litjens G, Barentsz J, Karssemeijer N, Huisman H . Clinical evaluation of a computer-aided diagnosis system for determining cancer aggressiveness in prostate MRI. Eur Radiol. 2015; 25(11):3187-99. PMC: 4595541. DOI: 10.1007/s00330-015-3743-y. View